The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
Vaibhav Suryavanshi, a 13-year-old cricketer from Bihar, has made history by becoming the youngest player…
The IPL Winners List stands out as a highly searched topic related to the Indian…
Fog is a natural weather condition that happens when water droplets hang in the air,…
December, the last month of the year, is a month full of important days that…
"Punjab Kesari" means "The Lion of Punjab." This title is given to Lala Lajpat Rai,…
India scripted history, on November 25, 2024, with a massive 295-run victory against Australia in…